1S7 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cartesian Therapeutics Inc

Watchlist Manager

Watchlist

Price: 13.242 EUR Market Closed

Market Cap: €8.7B

C	Cartesian Therapeutics Inc SWB:1S7	US
	Northeast Community Bancorp Inc NASDAQ:NECB	US
F	Fuelcell Energy Inc F:FEY2	US
S	Singapore Telecommunications Ltd XBER:SIT4	SG
N	NVIDIA Corp F:NVD	US
	Southstone Minerals Ltd XTSX:SML	CA
	FG Financial Group Inc F:LU5	US
	Buckle Inc NYSE:BKE	US
	Nanophase Technologies Corp NASDAQ:SLSN	US
	Equinor ASA OSE:EQNR	NO
C	CNOOC Ltd F:NC2A	CN
A	Autopedia Sukses Lestari Tbk PT IDX:ASLC	ID
	Equity Residential NYSE:EQR	US
	Orange SA PAR:ORA	FR
	MEI Pharma Inc NASDAQ:LITS	US

Profitability Summary

Cartesian Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-8 339%

Negative 3Y Average Operating Margin

-1 856%

Declining Operating Margin

-18% > -8 339%

Negative Net Margin

-8 699%

Negative 3Y Average Net Margin

-1 779%

Declining Net Margin

-18% > -8 699%

Negative Free Cash Flow Margin

-4 359%

Negative 3Y Average Free Cash Flow Margin

-1 182%

Declining Free Cash Flow Margin

-36% > -4 359%

Exceptional ROE

182%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-64%

Declining ROIC

-52% > -75%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.